Physician Wealth Advisors’s Murphy USA MUSA Stock Holding History

Physician Wealth Advisors’s Portfolio MUSA Stock Details MUSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.16K	Buy	4 +2	+100%	+$1.09K	﹤0.01%	1479
2026 Q1	$988	Buy	+2	New	+$856	﹤0.01%	1699

Other funds holding MUSA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Physician Wealth Advisors's MUSA Position: Q2 2026 in Review

Physician Wealth Advisors increased its Murphy USA (MUSA) stake by 100% in Q2 2026, buying an estimated $1.09K and bringing the position to 4 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #1479.

Physician Wealth Advisors first reported a position in MUSA in Q1 2026 and has held it in 2 quarters since. 606 funds tracked by Wall St. Rank hold MUSA as of Q2 2026.

Physician Wealth Advisors held 4 shares of Murphy USA worth $2.16K as of Q2 2026.
Physician Wealth Advisors bought 2 Murphy USA shares in Q2 2026, an estimated $1.09K.
Murphy USA made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1479 holding.
Physician Wealth Advisors first reported a position in Murphy USA in Q1 2026 and has held it in 2 quarters since.
606 funds tracked by Wall St. Rank held Murphy USA as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.